Progressive Care (RXMD)
(Delayed Data from OTC)
$1.91 USD
-0.33 (-14.82%)
Updated May 17, 2024 09:57 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
RXMD 1.91 -0.33(-14.82%)
Will RXMD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for RXMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for RXMD
Progressive Care Inc. Announces Record First Quarter 2024 Revenues of $14.6 Million, an Increase of 28% Over First Quarter 2023 Results
Progressive Care Releases Q1 2024 Financial Highlights
NextPlat Reports Record Consolidated Q1 2024 Revenues of $17.5 Million Compared to $2.9 Million in Q1 2023 (508% Increase) as Quarterly Margins Improve to 27.5%
Progressive Care reports Q1 results
Progressive Care’s Strategic Merger with NextPlat to Reshape Healthcare